Lawrence H. Schwartz

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

2.9Author DataRank

Indexed papers

5in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 5 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400F, NCT03373760)

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002973

Top 11%

1.9DataRank

Top 11%47 citations

Mary W. Redman, Naiyer A. Rizvi, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +14 more

Papers

Driven by 45 papers — median percentile 35. Top paper: “Identification of Non–Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics”.

Identification of Non–Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2942

N/A

5.8DataRank · unranked

178 citations

Matthew Fronheiser, Lin Lü, Shuyan Du, Wendy Hayes, David Leung +7 more

Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy (RT) for borderline resectable (BR) adenocarcinoma of the pancreas.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.377

N/A

5.8DataRank · unranked

144 citations

Qian Shi, Jeffrey P. Meyers, Joseph M. Herman, Michael Choung, Brian M. Wolpin +13 more

Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial

Blood(2020)10.1182/blood.2019003277

N/A

3.7DataRank · unranked

95 citations

Mei‐Yin C. Polley, Michael V. Knopp, Nathan C. Hall, Lale Kostakoglu, Jun Zhang +14 more

Deep learning for the prediction of early on-treatment response in metastatic colorectal cancer from serial medical imaging

Nature Communications(2021)10.1038/s41467-021-26990-6

N/A

3.7DataRank · unranked

101 citations

Laurent Dercle, Binsheng Zhao, Lawrence H. Schwartz, Lin Lü

Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer

JAMA Oncology(2021)10.1001/jamaoncol.2021.2209

N/A

3.1DataRank · unranked

105 citations

Mary W. Redman, Lyudmila Bazhenova, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +14 more

A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753)

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.09.013

N/A

2.3DataRank · unranked

79 citations

Mary W. Redman, Susanne M. Arnold, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +12 more

Phase II study of durvalumab plus tremelimumab as therapy for patients with previously treated anti-PD-1/PD-L1 resistant stage IV squamous cell lung cancer (Lung-MAP substudy S1400F, NCT03373760)

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002973

Top 11%

1.9DataRank

Top 11%47 citations

Mary W. Redman, Naiyer A. Rizvi, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +14 more

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

European Journal of Cancer(2009)10.1016/j.ejca.2008.10.026

N/A

1.5DataRank · unranked

29148 citations

P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford +25 more

Quantitative imaging metrics derived from magnetic resonance fingerprinting using ISMRM/NIST MRI system phantom: An international multicenter repeatability and reproducibility study

Medical Physics(2021)10.1002/mp.14833

Top 25%

0.810DataRank

Top 25%26 citations

Enlin Qian, Sairam Geethanath, Guido Buonincontri, Nancy A. Obuchowski, Maggie Fung +7 more

Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol

The Lancet Oncology(2020)10.1016/s1470-2045(20)30475-7

N/A

0.725DataRank · unranked

125 citations

Vassiliki A. Papadimitrakopoulou, Katherine Minichiello, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +21 more

Enhanced Detection of Treatment Effects on Metastatic Colorectal Cancer with Volumetric CT Measurements for Tumor Burden Growth Rate Evaluation

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1493

N/A

0.546DataRank · unranked

37 citations

Julia Wilkerson, Sanja Karovic, Binsheng Zhao, Jessica Flynn, Mengxi Zhou +13 more

Multiparametric MRI and artificial intelligence in predicting and monitoring treatment response in bladder cancer

Insights into Imaging(2025)10.1186/s13244-024-01884-5

N/A

0.500DataRank · unranked

27 citations

Thomas C. Kwee, Oğuz Akın, Keisuke Shigeta, Ramesh Paudyal, Christian Roest +10 more

Baseline Radiomic Signature to Estimate Overall Survival in Patients With NSCLC

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2022.12.019

N/A

0.489DataRank · unranked

25 citations

Matthew Fronheiser, Naiyer A. Rizvi, Matthew D. Hellmann, Sabine Maier, Wendy Hayes +7 more

Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop

The Lancet Oncology(2023)10.1016/s1470-2045(22)00742-2

N/A

0.489DataRank · unranked

25 citations

Heiko Schöder, Elad Sharon, Jedd D. Wolchok, Michael V. Knopp, Richard L. Wahl +18 more

A Quantitative Multiparametric MRI Analysis Platform for Estimation of Robust Imaging Biomarkers in Clinical Oncology

Tomography(2023)10.3390/tomography9060161

N/A

0.345DataRank · unranked

9 citations

Ramesh Paudyal, Amaresha Shridhar Konar, Peter S. LaViolette, Oğuz Akın, Vaios Hatzoglou +8 more

Is local review of positron emission tomography scans sufficient in diffuse large B‐cell lymphoma clinical trials? A CALGB 50303 analysis

Cancer Medicine(2023)10.1002/cam4.5628

N/A

0.320DataRank · unranked

5 citations

Levi Pederson, Michael V. Knopp, David Poon, Jun Zhang, Brad S. Kahl +10 more

Can MRI radiomics distinguish residual adenocarcinoma from acellular mucin in treated rectal cancer?

European Journal of Radiology(2025)10.1016/j.ejrad.2025.111986

N/A

0.292DataRank · unranked

6 citations

Abdalla Ibrahim, Akshay Baheti, Peter Gibbs, Shannon P. Sheedy, Sonia Lee +16 more

CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma

Cancer Research Communications(2024)10.1158/2767-9764.crc-22-0516

N/A

0.216DataRank · unranked

2 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Qian Shi, Priya Kumthekar +16 more

Impact of artificial intelligence-based and traditional image preprocessing and resampling on MRI-based radiomics for classification of papillary thyroid carcinoma

BJR|Artificial Intelligence(2025)10.1093/bjrai/ubaf006

Top 65%

0.208DataRank

Top 65%3 citations

Ramesh Paudyal, Akash Shah, Nora Katabi, Vaios Hatzoglou, Binsheng Zhao +7 more

Alliance/CALGB 80802: Impact of hepatitis C (HCV) on doxorubicin (DO) + sorafenib (S) versus S in patients (pts) with advanced hepatocellular carcinoma (aHCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.325

N/A

0.202DataRank · unranked

2 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Qian Shi, Sawyer Jacobson +12 more

Radiomic signatures to predict survival in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib +/- doxorubicin: Correlative science from CALGB 80802 (Alliance).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.343

N/A

0.184DataRank · unranked

1 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Qian Shi, Sawyer Jacobson +12 more

Lung-MAP (SWOG S1400): Design, implementation, and lessons learned from a biomarker-driven master protocol (BDMP) for previously-treated squamous lung cancer (sqNSCLC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9576

N/A

0.165DataRank · unranked

2 citations

Vassiliki A. Papadimitrakopoulou, Katherine Minichiello, David R. Gandara, Fred R. Hirsch, Philip C. Mack +14 more

Artificial intelligence and radiomics biomarkers for treatment response prediction in advanced HER2-negative breast cancer

The Breast(2025)10.1016/j.breast.2025.104571

N/A

0.165DataRank · unranked

2 citations

Jeremy McGale, Binsheng Zhao, Julia Schmitt, Alexander Peltzer, Lawrence H. Schwartz +2 more

Correction of Gradient Nonlinearity Bias in Apparent Diffusion Coefficient Measurement for Head and Neck Cancers Using Single- and Multi-Shot Echo Planar Diffusion Imaging

Cancers(2025)10.3390/cancers17111796

N/A

0.104DataRank · unranked

1 citations

Alfonso Lema-Dopico, Akash Shah, Vaios Hatzoglou, Muhammad Awais, Eric Aliotta +7 more

Variability of HCC Tumor Diameter and Density Measurements on Dynamic Contrast-Enhanced Computed Tomography

Tomography(2025)10.3390/tomography11030036

N/A

0.104DataRank · unranked

1 citations

Abdalla Ibrahim, Pengfei Geng, Qian Wu, Yen Chou, Oğuz Akın +4 more

Discordance between central versus local response assessments in neuroendocrine tumor (NET) patients (pts) enrolled in A021202.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.361

Top 100%

0DataRank

Top 100%0 citations

Michelle R. Mahoney, Timothy R. Asmis, Nathan C. Hall, Sanja Karovic, Michael V. Knopp +9 more

Clinical Trial Design and Development Work Group Within the Quantitative Imaging Network

Tomography(2020)10.18383/j.tom.2019.00022

N/A

0DataRank · unranked

3 citations

John M. Buatti, Hui‐Kuo G. Shu, Richard L. Wahl, Brenda F. Kurland, Hannah M. Linden +8 more

SWOG S1400F (NCT03373760): A phase II study of durvalumab plus tremelimumab for previously treated patients with acquired resistance to PD-1 checkpoint inhibitor therapy and stage IV squamous cell lung cancer (Lung-MAP Sub-study).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.9623

Top 100%

0DataRank

Top 100%0 citations

Mary W. Redman, Naiyer A. Rizvi, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +14 more

Phase II Study of a Non-Platinum–Containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab as Initial Therapy for Patients with Advanced Lung Adenocarcinomas

UNC Libraries(2020)10.17615/d2gv-4708

N/A

0DataRank · unranked

0 citations

Matthew D. Hellmann, Alex Lash, Mary Shaw, Lauren J. Rogak, Pietanza +9 more

Multi-site, multi-platform comparison of MRI T1 measurement using the system phantom

PLoS ONE(2021)10.1371/journal.pone.0252966

N/A

0DataRank · unranked

53 citations

Zydrunas Gimbutas, Andrew Dienstfrey, Karl F. Stupic, Michael A. Boss, Stephen E. Russek +15 more

Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair–Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G

Clinical Lung Cancer(2021)10.1016/j.cllc.2021.01.001

N/A

0DataRank · unranked

32 citations

Mary W. Redman, Lauren A. Byers, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +12 more

Prospective evaluation of 18F-FDG positron emission tomography in the preoperative staging of patients with hepatic colorectal metastases

HepatoBiliary Surgery and Nutrition(2021)10.21037/hbsn-19-357

N/A

0DataRank · unranked

7 citations

Mithat Gönen, Raymond E. Baser, Lawrence H. Schwartz, Scott Tuorto, Lynn A. Brody +5 more

Convolutional Neural Network Addresses the Confounding Impact of CT Reconstruction Kernels on Radiomics Studies

Tomography(2021)10.3390/tomography7040074

N/A

0DataRank · unranked

2 citations

Shawn Sun, Manjun Xiao, Hao Yang, Lin Lü, Yajun Li +3 more

Condensed table of contents

The Journal of Thoracic and Cardiovascular Surgery(2005)10.1016/s0022-5223(04)01777-5

N/A

0DataRank · unranked

0 citations

S Mussa, Bishwa Bhaskar Choudhary, David P. Taggart, Juan A. Crestanello, Claude Deschamps +127 more

The Impact of Image Acquisition Parameters and ComBat Harmonization on the Predictive Performance of Radiomics: A Renal Cell Carcinoma Model

Applied Sciences(2022)10.3390/app12199824

N/A

0DataRank · unranked

15 citations

Lin Lu, Hao Yang, Oğuz Akın, Lawrence H. Schwartz, Binsheng Zhao +1 more

Multiparametric MRI in Era of Artificial Intelligence for Bladder Cancer Therapies

Cancers(2023)10.3390/cancers15225468

N/A

0DataRank · unranked

18 citations

Alfonso Lema-Dopico, Ramesh Paudyal, Amaresha Shridhar Konar, Thomas L. Chenevert, Dariya Malyarenko +8 more

Alliance A032002 (ART): Phase II randomized trial of atezolizumab versus atezolizumab and radiation therapy for platinum-ineligible/refractory metastatic urothelial cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.tps589

N/A

0DataRank · unranked

1 citations

Karla V. Ballman, Scott T. Tagawa, Alan Tan, Bishoy M. Faltas, Arshin Sheybani +11 more

Three-Dimensional Margin as a Predictor of Local Tumor Progression after Microwave Ablation: Intraprocedural versus 4–8-Week Postablation Assessment

Journal of Vascular and Interventional Radiology(2024)10.1016/j.jvir.2024.01.001

N/A

0DataRank · unranked

28 citations

Vlasios S. Sotirchos, Assen S. Kirov, Daniel Lafontaine, Mithat Gönen, Randy Yeh +9 more

Machine learning-based identification of contrast-enhancement phase of computed tomography scans

PLoS ONE(2024)10.1371/journal.pone.0294581

N/A

0DataRank · unranked

1 citations

Abdalla Ibrahim, Qian Wu, Pengfei Geng, Yen Chou, Hao Yang +7 more

Advancements in artificial intelligence for prostate cancer: Optimizing diagnosis, treatment, and prognostic assessment

Asian journal of urology(2025)10.1016/j.ajur.2024.12.001

N/A

0DataRank · unranked

26 citations

Christian Roest, Thomas C. Kwee, Ramesh Paudyal, Alfonso Lema-Dopico, Stefan J. Fransen +9 more

End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer

Journal of Clinical Oncology(2025)10.1200/jco-25-01608

N/A

0DataRank · unranked

16 citations

Matthew D. Galsky, Nazlı Dizman, David H. Aggen, Neeraj Agarwal, Hikmat Al‐Ahmadie +39 more

Dual-Stage AI Model for Enhanced CT Imaging: Precision Segmentation of Kidney and Tumors

Tomography(2025)10.3390/tomography11010003

N/A

0DataRank · unranked

11 citations

Lin Lu, Hao Yang, Pengfei Geng, Oğuz Akın, Helena Furberg +3 more

Comparing quantitative imaging biomarker alliance volumetric CT classifications with RECIST response categories

Radiology Advances(2025)10.1093/radadv/umaf001

N/A

0DataRank · unranked

2 citations

Nancy A. Obuchowski, Hao Yang, Yen Chou, Hong Ma, Pingzhen Guo +4 more

Radiomic signatures to estimate survival in patients with advanced hepatocellular carcinoma treated with sorafenib: Cancer and Leukemia Group B 80802 (Alliance)

ESMO Open(2025)10.1016/j.esmoop.2025.105848

N/A

0DataRank · unranked

1 citations

Susan M. Geyer, Andrew B. Nixon, Federico Innocenti, Q. Shi, Steven Jacobson +15 more

A novel predictive model using changes in clinical and serum biomarkers and automated quantitative imaging for mCRPC patients treated with AR-directed therapy.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.5_suppl.264

N/A

0DataRank · unranked

0 citations

Jessica Flynn, Binsheng Zhao, Aseem Anand, Karl Sjöstrand, Steven M. Larson +7 more

Lawrence H. Schwartz

Indexed papers

Top data-sharing exemplar

Papers